Cumberland Pharmaceuticals Inc.
Compositions and Methods of Treating Cardiac Fibrosis with Ifetroban
Last updated:
Abstract:
The present invention is directed to methods of treating, preventing, and/or ameliorating fibrosis syndrome, and in particular cardiac fibrosis, by administration of a therapeutically effective amount of ifetroban, or a pharmaceutically acceptable salt thereof.
Status:
Application
Type:
Utility
Filling date:
17 Jan 2021
Issue date:
13 May 2021